Eagle Bay Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-66
Closed -$5.15K 719
2024
Q4
$5.15K Sell
66
-1
-1% -$78 ﹤0.01% 697
2024
Q3
$4.83K Sell
67
-37
-36% -$2.62K ﹤0.01% 1020
2024
Q2
$7.16K Sell
104
-64
-38% -$4.34K ﹤0.01% 627
2024
Q1
$12.2K Sell
168
-35
-17% -$2.34K 0.01% 536
2023
Q4
$12.4K Sell
203
-1,320
-87% -$78.4K 0.01% 487
2023
Q3
$87.1K Buy
1,523
+319
+26% +$19.3K 0.04% 280
2023
Q2
$71.5K Sell
1,204
-152
-11% -$9.1K 0.04% 296
2023
Q1
$84.9K Sell
1,356
-178
-12% -$11.1K 0.05% 282
2022
Q4
$96K Buy
1,534
+826
+117% +$47.4K 0.05% 246
2022
Q3
$35K Sell
708
-579
-45% -$32.1K 0.02% 426
2022
Q2
$75.7K Buy
1,287
+799
+164% +$44K 0.05% 265
2022
Q1
$26K Buy
488
+30
+7% +$1.73K 0.02% 217
2021
Q4
$28K Sell
458
-151
-25% -$8.96K 0.02% 502
2021
Q3
$34K Sell
609
-75
-11% -$4.12K 0.02% 496
2021
Q2
$37K Buy
+684
New +$32.9K 0.03% 413

Other funds holding PBH

Eagle Bay Advisors's PBH Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Prestige Consumer Healthcare (PBH) in Q1 2025, closing a stake of 66 shares — an estimated $5.15K sold.

Eagle Bay Advisors first reported a position in PBH in Q2 2021 and held it in 15 quarters. The position peaked at $96K in Q4 2022. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Prestige Consumer Healthcare position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 66 Prestige Consumer Healthcare shares in Q1 2025, an estimated $5.15K.
  • Eagle Bay Advisors first reported a position in Prestige Consumer Healthcare in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Prestige Consumer Healthcare position peaked at $96K in Q4 2022.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.